BridgeBio Pharma, Inc. - COM (BBIO)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
171M
Holdings value Q3 2024
$4.36B
Value change Q3 2024
-$99.4M
Grand Portfolio weight change Q3 2024
0%
Number of holders
247
Number of buys Q3 2024
138
Number of sells Q3 2024
-106
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 171M $4.36B -$99.4M $25.46 254
2024 Q2 175M $4.43B +$85.4M $25.33 252
2024 Q1 170M $5.26B +$115M $30.92 241
2023 Q4 166M $6.68B +$159M $40.37 251
2023 Q3 161M $4.23B +$298M $26.37 221
2023 Q2 150M $2.58B -$39.9M $17.20 205
2023 Q1 152M $2.52B +$155M $16.58 218
2022 Q4 145M $1.1B -$14.6M $7.62 174
2022 Q3 145M $1.44B +$48.7M $9.94 171
2022 Q2 140M $1.27B -$23.5M $9.08 157
2022 Q1 143M $1.45B -$23.8M $10.15 168
2021 Q4 142M $2.37B -$117M $16.68 194
2021 Q3 140M $6.56B -$164M $46.87 208
2021 Q2 143M $8.69B +$97.6M $60.96 201
2021 Q1 141M $8.68B +$1.24B $61.60 196
2020 Q4 121M $8.61B +$173M $71.11 164
2020 Q3 118M $4.39B +$21.6M $37.52 129
2020 Q2 117M $3.82B +$146M $32.61 117
2020 Q1 113M $3.27B +$162M $29.00 93
2019 Q4 100M $3.52B +$148M $35.05 84
2019 Q3 103M $2.22B +$112M $21.47 74
2019 Q2 99.9M $2.7B +$2.7B $26.97 60